Ischemic Stroke — Cortex Motor Function Reorganization in Stroke Patients
Citation(s)
Boyeson MG Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke. 1996 Nov;27(11):2145-6.
Calautti C, Leroy F, Guincestre JY, Baron JC Dynamics of motor network overactivation after striatocapsular stroke: a longitudinal PET study using a fixed-performance paradigm. Stroke. 2001 Nov;32(11):2534-42.
Cheng YD, Al-Khoury L, Zivin JA Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx. 2004 Jan;1(1):36-45. Review.
Coppell AL, Pei Q, Zetterström TS Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology. 2003 Jun;44(7):903-10.
Goldstein LB Effects of amphetamines and small related molecules on recovery after stroke in animals and man. Neuropharmacology. 2000 Mar 3;39(5):852-9. Review.
James GA, Lu ZL, VanMeter JW, Sathian K, Hu XP, Butler AJ Changes in resting state effective connectivity in the motor network following rehabilitation of upper extremity poststroke paresis. Top Stroke Rehabil. 2009 Jul-Aug;16(4):270-81. doi: 10.1310/tsr1604-270.
Kokotilo KJ, Eng JJ, McKeown MJ, Boyd LA Greater activation of secondary motor areas is related to less arm use after stroke. Neurorehabil Neural Repair. 2010 Jan;24(1):78-87. doi: 10.1177/1545968309345269. Epub 2009 Sep 8.
Mattson MP, Maudsley S, Martin B BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 2004 Oct;27(10):589-94.
Nudo RJ, Milliken GW Reorganization of movement representations in primary motor cortex following focal ischemic infarcts in adult squirrel monkeys. J Neurophysiol. 1996 May;75(5):2144-9.
Page SJ, Harnish SM, Lamy M, Eliassen JC, Szaflarski JP Affected arm use and cortical change in stroke patients exhibiting minimal hand movement. Neurorehabil Neural Repair. 2010 Feb;24(2):195-203. doi: 10.1177/1545968309360501. Erratum in: Neurorehabil Neural Repair. 2010 Jun;24(5):495.
Page SJ, Szaflarski JP, Eliassen JC, Pan H, Cramer SC Cortical plasticity following motor skill learning during mental practice in stroke. Neurorehabil Neural Repair. 2009 May;23(4):382-8. doi: 10.1177/1545968308326427. Epub 2009 Jan 20.
Rossini PM, Dal Forno G Integrated technology for evaluation of brain function and neural plasticity. Phys Med Rehabil Clin N Am. 2004 Feb;15(1):263-306. Review.
Semkova I, Wolz P, Krieglstein J Neuroprotective effect of 5-HT1A receptor agonist, Bay X 3702, demonstrated in vitro and in vivo. Eur J Pharmacol. 1998 Oct 23;359(2-3):251-60.
Swayne OB, Rothwell JC, Ward NS, Greenwood RJ Stages of motor output reorganization after hemispheric stroke suggested by longitudinal studies of cortical physiology. Cereb Cortex. 2008 Aug;18(8):1909-22. doi: 10.1093/cercor/bhm218. Epub 2008 Jan 29.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.